--- title: "Animal Testing Alternative: Reducing Animal Testing & Experimentation" description: Explore Animal Testing Alternative by Quantiphi — An AI-empowered Digital Animal Replacement Technology to reform pharma and life science research and reduce animal testing and experimentation dependency. --- [![Q logo_dark-1](https://ai.quantiphi.com/hs-fs/hubfs/Q%20logo_dark-1.png?quality=high&width=159&height=42&name=Q%20logo_dark-1.png "Q logo_dark-1")](https://quantiphi.com) - [Default HubSpot Blog](https://5145473.hs-sites.com/blog) # DART: An Animal-Free Testing Alternative   ![](https://ai.quantiphi.com/hubfs/DART%20logo_dark%20BG.svg) ## DART: An Animal-Free Testing Alternative Non-animal, non-biopsy, AI-based workstation solution for predicting safety and efficacy in Biopharma and Pharmaceutical industries.                 [Watch a Demo](https://ai.quantiphi.com/digital-animal-replacement-technology#download) ![human-psy](https://cdn.quantiphi.com/2024/07/Application-Database-Migration-icon-1.svg) ### Replacement DART eliminates the need for animal testing by using AI-driven simulations and in vitro platforms to predict safety concerns during R&D, clinical trials, and production phases. ![no-animals](https://cdn.quantiphi.com/2024/07/Application-Migration.svg) ### Reduction DART supports a gradual reduction in animal testing by providing reliable predictions that decrease the number of animals needed, facilitating a transition to fully animal-free testing methods. ![cost-eff](https://cdn.quantiphi.com/2024/07/Extract-icon.svg) ### Refinement DART enhances testing precision and relevance to human physiology, integrating seamlessly into existing workflows and significantly reducing testing time. ## Commit to animal cruelty-free testing --- With the FDA passing the Modernization Act 2.0 in December 2022 and the European Parliament adopting a resolution to phase out animal testing in September 2022, the need for the shift is more urgent than ever. DART enables you to predict and manage safety concerns such as neurovirulence, neurotoxicity, and sterility in the workflow during the R&D, clinical trials, and production phases without involving animal experimentation. ![human-psy](https://ai.quantiphi.com/hubfs/human-psy.svg) Higher relevance to human physiology  ![no-animals](https://ai.quantiphi.com/hubfs/no-animals.svg) No animal experimentation or biopsies ![cost-eff](https://ai.quantiphi.com/hubfs/cost-eff.svg) Cost effective modern approach ![integrate](https://ai.quantiphi.com/hubfs/integrate.svg)  Enhanced prediction accuracy with ML models ![icons 6](https://ai.quantiphi.com/hubfs/icons%206.svg) Seamless integration into the company’s existing quality check workflow ![time-eff](https://ai.quantiphi.com/hubfs/time-eff.svg) Reduction in testing time drastically ![Get Human Relevant Drug Testing Results](https://ai.quantiphi.com/hs-fs/hubfs/Get%20Human%20Relevant%20Drug%20Testing%20Results.png?width=470&height=269&name=Get%20Human%20Relevant%20Drug%20Testing%20Results.png) ## Get Human-Relevant Drug Testing Results --- DART uses advanced deep-learning neural network algorithms and ethically-sourced human stem cells to generate highly accurate human-relevant scientific data.  ## Change the traditional way of safety and efficacy assessments --- ![An in-vitro platform-1](https://ai.quantiphi.com/hs-fs/hubfs/An%20in-vitro%20platform-1.png?width=178&height=168&name=An%20in-vitro%20platform-1.png) An in-vitro platform that uses a human micro physiological system created from an ethically sourced biobank. ![digital workstation solution-1](https://ai.quantiphi.com/hs-fs/hubfs/digital%20workstation%20solution-1.png?width=178&height=165&name=digital%20workstation%20solution-1.png) A digital workstation solution to predict safety concerns by comparing with benchmark patterns derived through segmentation model training to provide accurate predictions. ## Accelerate Drug Discovery with Dart --- ![Batch Testing](https://ai.quantiphi.com/hs-fs/hubfs/Batch%20Testing.png?width=226&height=226&name=Batch%20Testing.png) ### ![number-circle-one-thin](https://ai.quantiphi.com/hubfs/number-circle-one-thin.svg)Batch Testing --- Prediction of neurovirulence and sterility in the vaccine production workflow ![Drug Discovery](https://ai.quantiphi.com/hs-fs/hubfs/Drug%20Discovery.png?width=226&height=226&name=Drug%20Discovery.png) ### ![number-circle-two-thin](https://ai.quantiphi.com/hubfs/number-circle-two-thin.svg) Drug Discovery  --- Prediction of neurovirulence in viral vaccine development process ![Antivenom Efficacy](https://ai.quantiphi.com/hs-fs/hubfs/Antivenom%20Efficacy.png?width=226&height=226&name=Antivenom%20Efficacy.png) ### ![number-circle-three-thin](https://ai.quantiphi.com/hubfs/number-circle-three-thin.svg)Antivenom Efficacy --- Prediction of antivenom potency and effectiveness ![Cell-Therapy](https://ai.quantiphi.com/hs-fs/hubfs/Cell-Therapy.png?width=226&height=226&name=Cell-Therapy.png) ### ![number-circle-four-thin](https://ai.quantiphi.com/hubfs/number-circle-four-thin.svg) Cell-Therapy  --- Prediction of CAR-T cell therapy-induced neurotoxicity   ## Learn more --- [![e423c609-webiste-l2-transcell-and-quantiphi](https://ai.quantiphi.com/hs-fs/hubfs/e423c609-webiste-l2-transcell-and-quantiphi.webp?width=283&height=148&name=e423c609-webiste-l2-transcell-and-quantiphi.webp) **Transcell and Quantiphi Announce Strategic Relationship **](https://quantiphi.com/media-releases/transcell-and-quantiphi-announce-strategic-relationship-to-transform-drug-discovery-and-development-sevices-with-analytics-machine-learning-and-cloud-solutions/) [![totalcare-pr](https://ai.quantiphi.com/hubfs/DART%20LP%20-%20Blog-Link---Banner.jpg) **Beyond Animal Testing: Ethical, Efficient & Effective Alternatives**](https://quantiphi.com/beyond-animal-testing-ethical-efficient-effective-alternatives/) [![totalcare-pr](https://ai.quantiphi.com/hubfs/DART%20LP%20-%20Financial-times-social-banner-.png) **Read about DART in the Financial Times**](https://www.ft.com/content/bddce737-a13b-4521-b431-85e8bcce2b14) [![totalcare-pr](https://ai.quantiphi.com/hubfs/DART%20LP%20-%20Whitepaper%20Banner.jpg) **Download a brochure about DART**](https://ai.quantiphi.com/hubfs/HCLS%20Collaterals%202023/DART%20-%20Quantiphi%20Brochure.pdf?hsLang=en) [![totalcare-pr](https://ai.quantiphi.com/hubfs/DART%20Upholding%20the%20Principles%20of%203Rs-Replacement%2c%20Reduction%2c%20and%20Refinement.webp) **DART: Upholding the Principles of 3Rs—Replacement, Reduction, and Refinement**](https://quantiphi.com/dart-upholding-the-principles-of-3rs-replacement-reduction-and-refinement/) [![totalcare-pr](https://ai.quantiphi.com/hubfs/DART%20Accelerating%20Efficacy%20and%20Toxicity%20Testing%20with%20Human%20Stem%20Cells%20and%20AI.webp) **DART: Accelerating Efficacy and Toxicity Testing with Human Stem Cells and AI**](https://quantiphi.com/dart-accelerating-efficacy-and-toxicity-testing-with-human-stem-cells-and-ai/)   **See DART in Action: View a Demo Now** ###### About Quantiphi Quantiphi is an award-winning AI-first digital engineering company driven by the desire to reimagine and realize transformational opportunities at the heart of business. We are passionate about our customers and obsessed with problem-solving to make products smarter, customer experiences frictionless, processes autonomous and businesses safer. [![linkedin-color-1](https://quantiphi.com/wp-content/themes/quantiphi/assets/img/linked.svg)](https://in.linkedin.com/company/quantiphi)[![twitter-color-1](https://quantiphi.com/wp-content/themes/quantiphi/assets/img/twitter.svg)](https://twitter.com/Quantiphi) ###### Quick Links - [Home](https://quantiphi.com/) - [Case Studies](https://quantiphi.com/resources/case-studies/) - [News](https://quantiphi.com/resources/newsroom/) - [Blogs](https://quantiphi.com/resources/blog/) - [Contact Us](https://quantiphi.com/contact-us/) - [Privacy Policy](https://quantiphi.com/privacy-policy/) ###### GLOBAL LOCATIONS ![Quantiphi-office-locations](https://ai.quantiphi.com/hs-fs/hubfs/Quantiphi-office-locations.png?width=336&name=Quantiphi-office-locations.png) ![](https://px.ads.linkedin.com/collect/?pid=633978&fmt=gif) ```json { "@context" : "https://schema.org", "@type" : "VideoObject", "contentUrl" : "https://5145473.fs1.hubspotusercontent-na1.net/hubfs/5145473/HCLS%20Collaterals%202023/DART%20Solution.mp4", "dateModified" : "2025-04-26T01:29:42.570Z", "duration" : "PT2M5.04S", "height" : 1080, "name" : "DART Solution", "thumbnailUrl" : "https://5145473.fs1.hubspotusercontent-na1.net/hubfs/5145473/HCLS%20Collaterals%202023/DART%20Solution.mp4/medium.jpg?t=1745630982570", "uploadDate" : "2023-06-14T13:04:58.059Z", "width" : 1920 } ```